American Association for Cancer Research
crc-23-0056_fig6.png (456.01 kB)

FIGURE 6 from Siglec-15 Promotes Evasion of Adaptive Immunity in B-cell Acute Lymphoblastic Leukemia

Download (456.01 kB)
posted on 2023-07-17, 14:20 authored by Claire E. Pillsbury, Jodi Dougan, Jennifer L. Rabe, Jairo A. Fonseca, Chengjing Zhou, Alyssa N. Evans, Hasan Abukharma, Ona Ichoku, Gloria Gonzalez-Flamenco, Sunita I. Park, Ahmed Aljudi, Deborah DeRyckere, Sharon M. Castellino, Sarwish Rafiq, Solomon Langermann, Linda N. Liu, Curtis J. Henry, Christopher C. Porter

Sig15 promotes an immunosuppressive tumor microenvironment in B-ALL. A–M, Unirradiated WT C57BL6 mice were injected via tail vein with 5 × 105 Cas9-only (n = 8 from two independent experiments) or Sig15 KO (n = 8) leukemia. Bone marrow was harvested 7 days later for highly dimensional flow cytometry of non-leukemia bone marrow populations. Healthy, leukemia-naïve mice (Naive) were included as controls (n = 6). CD3+ T cells (A), NK cells (B), classical dendritic cells (cDC; C), and neutrophils (D) were variably present at higher totals in the bone marrow of Sig15 KO recipient mice compared with control leukemia. E, Representative contour plots of T-cell populations. Proportions of CD8+ (F) but not CD4+ (G) T cells were higher in Sig15 KO recipients than control leukemia, increasing the CD8+/CD4+ T-cell ratio (H) to levels comparable with Naive mice. I, Degranulated CD8+ T cells were higher in Sig15 KO recipient mice, as were SLEC (J) and MPEC (K) CD8+ T-cell populations. Early memory-like populations consistent with central (L) and effector memory (M) CD8+ T-cell populations were also higher in Sig15 KO recipients. N–P, From the same experiments, bone marrow supernatant from control and Sig15 KO leukemia recipient mice was analyzed via 44-plex cytokine/chemokine assay. Levels of IL6 (N), LIF (O), and IL5 (P) were all significantly lower in the bone marrow of Sig15 KO recipients as compared with control leukemia (*, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001). Sig15 expression on B-ALL cells suppresses CD8+ T-cell expansion and activation and contributes overall to formation of a more proleukemia bone marrow microenvironment.


Leukemia and Lymphoma Society (LLS)

CURE Childhood Cancer (CURE)

Alex's Lemonade Stand Foundation for Childhood Cancer (ALSF)

현대자동차그룹 | Hyundai Motor America | Hyundai Hope On Wheels (Hope On Wheels)



We demonstrate that Sig15 is overexpressed in hematologic malignancies driven by NFκB, is required for immune evasion in a mouse model of leukemia, and, for the first time, that it circulates at high levels in the plasma of children with leukemia.